BUFFER FOR RAPID In Situ Hybridization

– 97% COSTS | – 50% TIME | No dedicated instrument needed

Pan-Flu Rapid PCR Typing kit

Omicron (BA.1, BA.2, Ba.2.12.1, BA.4 and  BA.5)
H1N1 | H3N2 (Flu-A) | Flu-B | RSV

KIT PCR COVID VARIANTS: we detect Omicron

One Step | CE-IVD | 45 mins PCR TIME

RELIABLE COVID-19 TESTS

LESS TIME FOR DIAGNOSIS, MORE TIME FOR LIFE

成立于2017年，位于博洛尼亚，OaCP是一家提供化学试剂以减少癌症基因诊断检测的时间（-97％）和成本（-50％）的意大利公司。公司的核心产品（Rapid-ISH和Smart-ISH杂交缓冲液）和辅助设备（Titan FISH探针）都已通过可行性验证，并获得欧盟CE-IVD认证。此外，OaCP探针也已通过CFDA认证。OaCP 技术已在欧盟，美国，中国和印度申请了专利，享有知识产权保护。

独自の試薬により精度を維持しながら癌の診断までの時間を72時間から2時間に短縮。コストも低減。

DoMo Genetics for Oncology

HOW DOES IT WORK?

Fast

WE REDUCE TEST TIME FROM 3 DAYS TO ONLY 2 HOURS

Easy to use

YOU DON’T CHANGE YOUR PROTOCOL, YOU SIMPLY ADD WITH THE PROBE

Affordable

WE REDUCE THE COSTS UP TO 50%

Tutorials

SEE OUR PROTOCOLS FOR FFPE TISSUES: FAST AND UNIVERSAL FISH

Among the many miseries diseases bring, the anguish of waiting for a diagnosis is one of the worst.
We mitigate some of this anguish by majorly reducing the time for diagnostic tests.

Our objective is to provide diagnostics laboratories and research institutions
with solutions that will disrupt diagnosis times and cost.

Our Products

ONCOLOGY

COVID-19

GLOBAL HEALTH

INSTRUMENT

OpenLab | OaCP As A Service

We’ve created OaCP among the benches of a lab. Since then, we’ve always worked on the improvement of our products.

We’ve been trusted by many partners for the validation of their products and their introduction to the Italian market.

We’ve also designed evolutions and addendums to partners’  products, working in conjunction with their R&D departments.

Starting from this multi-year R&D experience, we’ve decided to open our labs and knowledge to every company, research institution, university, lab, and everyone who needs support in the design, analysis, and optimization of:

DNA and RNA genome tools

Whole Genome Analysis

Pathogens (SARS-CoV-2 included) research and diagnostics design tools

Bioinformatics and statistical solutions

DNA and RNA genome tools

Design, analysis and optimization of oligonucleotides and probes for molecular diagnostics and research:

  • (q)PCR primers
  • qPCR probes
  • Design, analysis and optimization for TaqMan probes (dual- labelled)
  • Design, analysis and optimization for Molecular beacons probes
  • Design, analysis and optimization for Scorpions probes
  • qPCR probes with MGB technology and LNA ( Locked Nucleic Acid) technology
  • Preparation of customized qPCR diagnostic panels

Sequencing services and Genome editing

  • Crispr-Cas9 experimental design
  • EMSA (Electrophoretic Mobility Shift Assay/ Gel-Shift Assay) experimental design and primers/ probes preparation 
  • Site-direct mutagenesis 
  • SNP genotyping
  • CNV genotyping
  • Plasmid preparation: in silico cloning and optimization
  • Gene expression studies 

Pathogens (SARS-CoV-2 included) research and diagnostics design tools

  • Specific Proteins preparation: wuhCor1/SARS-CoV-2 – reference and variants: B.1.1.7/ B.1.351/ P1/ P2/ B.1.617/ B.1.617.1/ B.1.617.2/ B.1.617.3/ B.1.525/ B.1.526/ B.1.526.1/ B.1.526.2/B.1.427/ B.1.429.
  • Mutation analysis tools design
  • SARS-CoV-2 control sequences

Bioinformatics and statistical solutions

INSIGHTS

Omicron SARS-CoV-2, FLU-A/B e RSV: i nuovi nemici pubblici del sistema sanitario.

Il continuo monitoraggio del virus SARS-CoV-2 e delle sue varianti, tramite unica PCR, è lo strumento più efficace nelle mani dei sistemi sanitari mondiali per mantenere sotto controllo il virus responsabile della CoViD-19 ed intercettare sul nascere nuovi focolai. ...

Omicron-2, the “stealth” variant is becoming prevalent in Denmark and in many Asian countries

Omicron or B.1.1.529, the last “version” of SARS-CoV-2 original strain, was identified almost two months ago. Today, Omicron is going to replace Delta variant prevalence in almost all countries.  According to ECDC monitor of Gisaid data, at the moment we write,...

SGTF versus N501Y mutation detection in the diagnosis of the Omicron variant’s two clades: BA.1 and BA.2

Omicron tracked in 77 countries The latest WHO weekly report, dated 12/13/2021 reveals that the number of people affected by Omicron is increasing sharply worldwide. Omicron variant is characterised by more than 30 mutations in Spike region and has been split into two...

Individuata una nuova forma di Omicron invisibile ad alcuni KIT PCR: l’OMS sta valutando la separazione in BA.1 e BA.2

Nuova forma di variante Omicron Una nuova versione della variante Omicron (B.1.1.529) è stata recentemente messa sotto i riflettori dal gruppo Pango-designation, dopo che in pochissimi giorni decine di nuove rilevazioni sono state depositate nel database Gisaid,...

OaCP has reached the 2nd place in the 5th China (Shenzhen) Innovation & Entrepreneurship International Competition

OaCP has been awarded with the 2nd prize of the 5th China (Shenzhen) Innovation & Entrepreneurship International Competition. The "Fly With Shenzhen" competition aims at integrating innovation and entrepreneurship resources, assisting overseas innovation and...

OaCP in the top 5 Big Health companies of the China Overseas Talent Innovation and Entrepreneurship Competition

OaCP has won the 4th prize within the Big Health area of expertise of the China Overseas Talent Innovation and Entrepreneurship Competition promoted by Wuhan City. The competition is hosted by China Association for Science and Technology (CAST), People's Government of...

RT- PCR, the gold standard in CoViD-19 diagnosis: the most common pitfalls and their interpretations

The gold standard for SARS-CoV-2 diagnosis is the Reverse Transcriptase Polymerase Chain Reaction, aka RT-PCR or qRT-PCR. This technique has been introduced in 1983 (Saiki et al. 1985) and nowadays is widely used in the diagnosis of many pathologies, from infectious...

OaCP has made it to the Go Global Finals

The Judging Panel of the Go Global Awards has announced that OACP IE LTD has made the short-list for the Go Global Awards as Start-Up Exporter of the Year. Learn more on https://www.zghcl.net/chuangye/index-e.html THE GO GLOBAL AWARDS The International Trade Council’s...

Dai test oncologici ai tamponi rapidi, l’innovazione è nel nostro DNA

Intervista rilasciata dal nostro CEO Enrico Di Oto a Marco Bettazzi per la Repubblica Bologna, sezione Economia - 30 agosto 2021 Tra febbraio e marzo hanno sviluppato il primo tampone rapido al mondo per individuare le varianti del Covid, in collaborazione con una...

Delta Variant outbreak emergency: what and where

As the media have been writing for weeks, the DELTA variant (born as variant B.1.617.2), first identified in mid-2020, is spreading fast. According to last ECDC commentary, the highly infectious variant of concern (V.O.C.) DELTA is becoming  “dominant in much of the...